In ESCC, NRF2 overexpression is strongly associated with lymph node metastasis, tumor recurrence following surgery, and poorer overall survival outcomes [49,50,51,52]. This evidence concerns the gene NFE2L2 and metastatic malignant neoplasm in the lymph nodes.